Clinical and Organizational Innovation In Healthcare Organizations

Size: px
Start display at page:

Download "Clinical and Organizational Innovation In Healthcare Organizations"

Transcription

1 Clinical and Organizational Innovation In Healthcare Organizations June 2001 Jean-Louis Denis, PhD Marie-Dominique Beaulieu, MD, MSc Yann Hébert, PhD (cand.) Ann Langley, PhD Daniel Lozeau, PhD Raynald Pineault, MD, PhD Louise-Hélène Trottier, PhD (cand.) Decision-maker partners: L agence d évaluation des technologies et des modes d intervention en santé (AÉTMIS) Le Collège des médecins du Québec Funded by: Canadian Health Services Research Foundation Fonds de recherche en santé du Québec (FRSQ) HEALNet Agence d'évaluation des technologies et des modes d'intervention en santé (AÉTMIS)

2 Contact principal investigator at: Jean-Louis Denis Full Professor CHSRF/CIHR Chair Université de Montréal Montreal, Quebec Canada H3T 1A8 Telephone: (514) Fax: (514) This document is available on the Canadian Health Services Research Foundation web site ( For more information on the Canadian Health Services Research Foundation, contact the foundation at: 11 Holland Avenue, Suite 301 Ottawa, Ontario K1Y 4S1 Telephone: (613) Fax: (613) Ce document est disponible sur le site Web de la Fondation canadienne de la recherche sur les services de santé ( Pour de plus amples renseignements sur la Fondation canadienne de la recherche sur les services de santé, communiquez avec la Fondation à l adresse suivante : 11, avenue Holland, bureau 301 Ottawa (Ontario) K1Y 4S1 Courriel : communications@fcrss.ca Téléphone : (613) Télécopier : (613)

3 Clinical and Organizational Innovation In Healthcare Organizations Jean-Louis Denis, PhD 1 Marie-Dominique Beaulieu, MD, MSc 2 Yann Hébert, PhD (cand.) 3 Ann Langley, PhD 4 Daniel Lozeau, PhD 5 Raynald Pineault, MD, PhD 6 Louise-Hélène Trottier, PhD (cand.) 7 1 Full Professor, CHSRF/CIHR Chair, Université de Montréal 2 Full Professor, Chair Dr Sadok Besrour en médecine familiale, Université de Montréal 3 Doctoral student, Université du Québec à Montréal 4 Full Professor, École des Hautes Études Commerciales 5 Assistant Professor, École nationale d administration publique 6 Full Professor, Université de Montréal 7 Doctoral candidate, Université de Montréal Acknowledgements: We thank the Canadian Health Services Research Foundation (CHSRF), Bill , the Fonds de recherche en santé du Québec (FRSQ), HEALNet, the Agence d'évaluation des technologies et des modes d'intervention en santé (AÉTMIS) and the Quebec College of Physicians for supporting this study. We also thank the members of the Advisory Committee for their support to start this study. Finally, we also acknowledge all persons who agreed to meet with us throughout this research.

4 Key Implications for Decision Makers The healthcare sector is characterized by very strong dynamics of innovation. What factors advance or limit the adoption of innovations and what is the role of evidence in this process? Why can innovations with little evidence-based support be widely adopted while others strongly supported by evidence are largely overlooked? The study reveals the following. The dissemination and adoption of clinical and organizational innovations are influenced by players (clinicians, administrators, patients, etc.) who do not see the associated benefits and risks in the same way. The scientific evidence generally covers the hard core of an innovation (for example, effectiveness of a drug) whereas there often is little or no evidence on the strategies that must be developed to promote implementation of innovations (for example, the learning process for a complex new surgical technique). To intervene effectively and influence clinical practices, decision makers and managers must factor in the perceptions of players. They also must consider the status these players give to evidence, their interests, and the values brought into play by the innovations. Organizations would be wise to develop strategies to encourage clinical settings to discuss in detail the benefits and drawbacks of an innovation for patients, clinicians and organizations. Organizations and professionals must exercise some vigilance to promote controlled learning processes designed to limit the risks for patients and maximize the benefits of a clinical innovation. i

5 Executive Summary To provide better support for disseminating clinical innovations, many suggest using a model of evidence-based medicine. This approach emphasizes the importance of better understanding what helps or limits the adoption of innovations, as well as the role of evidence in these processes. We therefore conducted research guided by four questions: 1) Why can innovations with little evidence-based support be widely adopted while others strongly supported by evidence are largely overlooked? 2) What is the nature of evidence considered in processes for adopting innovations? 3) In what way do relationships between players and organizations in the healthcare system foster or inhibit the adoption of certain innovations? 4) What is the potential role of strategies developed to promote evidence-based medicine in the process of adopting innovations? Implications for managing innovations Decision makers and managers who wish to influence practices must consider the perceptions of players. They must also factor in the status these players give to evidence, their interests, and the values brought into play by innovations. The distribution of benefits and risks among players might explain in part adoption phenomena that appear to be irrational. This distribution also provides a potential mechanism for intervention to ensure the adoption of practices likely to enhance the healthcare system. By acting on this distribution of risks and benefits, they might be able to stimulate the adoption of certain innovations and better control the dissemination of others. The varying ability of clinicians and managers to conduct a critical assessment of the scientific evidence available must also be considered. This is partly why various people will identify a range of legitimate sources for evidence they consider relevant (for example, a clinical setting with a solid reputation, a clinician considered leader, scientific journals, conventions, etc.). Analysis revealed five dilemmas in the regulation of new technologies and healthcare practices: Dilemma # 1: The dissemination and adoption of clinical innovations must be rationally based on solid, clearly defined scientific evidence. Evidence also forms part of a complex social dynamic, which means that players and organizations will not reach the same conclusions on the nature and scope of evidence. Dilemma # 2: Evidence-based medicine gives predominant weight to scientific evidence in the dissemination and adoption of clinical innovations. The scientific evidence associated with a clinical innovation is always partial, which means that dissemination and adoption of clinical innovations are inevitably accompanied by negotiations over the true nature of an innovation and the adaptations required for implementation. ii

6 Dilemma # 3: The dissemination and adoption of clinical innovations are generally addressed as a rational problem of bringing practices into compliance with standards. Retention of clinical innovations is also dependent on ideological factors and the interests of the players and organizations involved. Dilemma # 4: The dissemination and adoption of clinical innovations require varying periods of experimentation. Experimentation can generate risks and limit the benefits of a clinical innovation. Dilemma # 5: The dissemination and adoption of clinical innovations are often accompanied by pressure for standardization. This means that everyone (players and organizations) agrees, which is not necessarily consistent with innovative dynamics. In general, these dilemmas suggest that the process for disseminating and adopting clinical innovations is related to a rational process in very special circumstances. Thus, the probability of adoption of clinical innovations will be high where: The interests and values of players, groups and organizations may be specifically recognized and, to some extent, are met; and The players, groups and organizations are able to state their preference and develop compromises. It appears that players, groups and organizations place growing importance on scientific evidence where it supports the validity of an innovation. However, where a series of other social and organizational factors favour a clinical innovation, there is little likelihood of widespread adoption with a tight timeline given the evidence available. In this case, there may be fad effects of the type, everyone is doing it, so we must too, in which the presence of serious coercive pressure such as the risk of losing a market may be enough to promote an innovation. This dynamic can be accompanied by a different positioning of the evidence. The evidence could arise during the process to alert players of the risks their new practices may pose. Approach The analysis focused on the process of disseminating four clinical innovations with organizational consequences. The first case involves the use of low molecular weight heparins (LMWH) to treat deep thrombophlebitis. This is a new practice with well established evidence that appears to be gaining wide adoption (a success story). The second case involves a surgical procedure, laparoscopic cholecystectomy. This is a case of over-adoption in which the dissemination curve has far outpaced the emergence of evidence. iii

7 The third case involves reusable hemodialyzer. This is an ambiguous case for which the dissemination process can be described as cautious. The fourth case, initially described as under-adopt, is intensive monitoring in the community for patients with serious psychiatric problems. The four cases were selected in conjunction with a committee of experts to cover the various options in terms of adoption speed (fast and slow) and the availability of evidence (early, late or ambiguous). For each case, the state of the evidence available and the process of adoption throughout the Montreal area were studied in light of statistical data and 63 in-depth interviews. The analysis was conducted in two phases: first, by identifying the specific issues raised by each case, and then by making comparisons between cases. iv

Explaining Diffusion Patterns for Complex Health Care Innovations

Explaining Diffusion Patterns for Complex Health Care Innovations Explaining Diffusion Patterns for Complex Health Care Innovations Jean-Louis Denis, Yann Hébert, Ann Langley, Daniel Lozeau, and Louise-Hélène Trottier Why are some less solidly supported health care innovations

More information

Processes and mechanisms for contextualizing scientific evidence Moving from HTA to HTPA?

Processes and mechanisms for contextualizing scientific evidence Moving from HTA to HTPA? Processes and mechanisms for contextualizing scientific evidence Moving from HTA to HTPA? Véronique Déry MD MSc, Sylvie Beauchamp PhD, Reiner Banken MD MSc, Lise-Ann Davignon MSc From Evidence to Policy

More information

MEMORANDUM OF UNDERSTANDING

MEMORANDUM OF UNDERSTANDING MEMORANDUM OF UNDERSTANDING BETWEEN THE GOUVERNEMENT DU QUÉBEC AND THE GOVERNMENT OF ONTARIO REGARDING COOPERATION IN THE FIELD OF ARTIFICIAL INTELLIGENCE 2017 Regarding Cooperation in the Field of Artificial

More information

From Research to Action for Sustainable Cities

From Research to Action for Sustainable Cities From Research to Action for Sustainable Cities Kyoto Joint Workshop on Sustainable Cities Maryse Lassonde, OC, PhD, CQ, MSRC Scientific Director Fonds de recherche du Québec Nature et technologies October

More information

Government Priorities of the Day - Budget 2018 Speaker Biographies

Government Priorities of the Day - Budget 2018 Speaker Biographies Government Priorities of the Day - Budget 2018 Speaker Biographies Janique Caron, Assistant Comptroller General, Financial Management Sector, Treasury Board Secretariat Janique joined the Treasury Board

More information

December Eucomed HTA Position Paper UK support from ABHI

December Eucomed HTA Position Paper UK support from ABHI December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing

More information

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as: HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually

More information

SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements

SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM 2014 Revision (v3) New ideas & Improvements Department of Surgery Evidence Decision Support Program Resource Tool Box Regional Clinical

More information

Issues in Emerging Health Technologies Bulletin Process

Issues in Emerging Health Technologies Bulletin Process Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The

More information

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL

More information

Canadian Social Economy Hub Centre canadien d économie sociale. QuickTime and a TIFF (Uncompressed) decompressor are needed to see this picture.

Canadian Social Economy Hub Centre canadien d économie sociale. QuickTime and a TIFF (Uncompressed) decompressor are needed to see this picture. Canadian Social Economy Hub Centre canadien d économie sociale QuickTime and a TIFF (Uncompressed) decompressor are needed to see this picture. AGENDA 1. Background information on the Social Economy Suite

More information

Re: Gazette Notice No. DGSO Consultation on Renewal Process for 2300 MHz and 3500 MHz Licences

Re: Gazette Notice No. DGSO Consultation on Renewal Process for 2300 MHz and 3500 MHz Licences 5 Place Ville Marie, bureau 1700 Montréal (Québec) H3B 0B3 Telephone: (514) 764-4700 Fax: (514) 874-2625 telecom.regulatory@cogeco.com VIA E-MAIL 30 January 2013 Manager, Emerging Networks, DGSO Industry

More information

Health Informatics Principles - Excerpt -

Health Informatics Principles - Excerpt - Health Informatics Principles - Excerpt - Foundational Curriculum: Cluster 4: Informatics Module 7: The Informatics Process and Principles of Health Informatics Unit 2: Health Informatics Principles 1

More information

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Pan-Canadian Vision and Strategy for Health Services and Policy Research 2014 2019 EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA Partners involved Alberta Cancer

More information

The evolution of poker players gambling habits: a three-year cohort study

The evolution of poker players gambling habits: a three-year cohort study The evolution of poker players gambling habits: a three-year cohort study Magali Dufour 1, Ph.D. Élise Roy 1, MD., MSc. Natacha Brunelle 2, Ph.D. 1 Université de Sherbrooke, 2 Université du Québec à Trois-Rivières

More information

Guide to the Requirements for Public Information and Disclosure GD-99.3

Guide to the Requirements for Public Information and Disclosure GD-99.3 Guide to the Requirements for Public Information and Disclosure GD-99.3 November 2010 Guide to the Requirements for Public Information and Disclosure Guidance Document GD-99.3 Minister of Public Works

More information

Article. The Internet: A New Collection Method for the Census. by Anne-Marie Côté, Danielle Laroche

Article. The Internet: A New Collection Method for the Census. by Anne-Marie Côté, Danielle Laroche Component of Statistics Canada Catalogue no. 11-522-X Statistics Canada s International Symposium Series: Proceedings Article Symposium 2008: Data Collection: Challenges, Achievements and New Directions

More information

What s Ethics Got to Do

What s Ethics Got to Do What s Ethics Got to Do with Big Data? WHO University of Miami Ethics Consultation October 12, 2017 Eric M. Meslin, Ph.D., FCAHS President & CEO Council of Canadian Academies Eric M. Meslin, PhD, FCAHS

More information

Nominating Committee report Resolution for Member approval: NOMINATING COMMITTEE REPORT THAT the report of the Nominating Committee be accepted.

Nominating Committee report Resolution for Member approval: NOMINATING COMMITTEE REPORT THAT the report of the Nominating Committee be accepted. Nominating Committee report 2013 Resolution for Member approval: NOMINATING COMMITTEE REPORT THAT the report of the Nominating Committee be accepted. The Nominating Committee is chaired by the CFPC Past

More information

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints

More information

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry

More information

Health Technology Strategy 1.0. June 2004

Health Technology Strategy 1.0. June 2004 June 2004 Prepared by the Health Technology Assessment Task Group on behalf of the Federal / Provincial / Territorial Advisory Committee on Information and Emerging Technologies WHY A PAN-CANADIAN STRATEGY?

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

An Integrated Expert User with End User in Technology Acceptance Model for Actual Evaluation

An Integrated Expert User with End User in Technology Acceptance Model for Actual Evaluation Computer and Information Science; Vol. 9, No. 1; 2016 ISSN 1913-8989 E-ISSN 1913-8997 Published by Canadian Center of Science and Education An Integrated Expert User with End User in Technology Acceptance

More information

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital

More information

Vincent RIALLE. Maître de conférences-praticien hospitalier, Dr GBM, Dr éthique médicale et biologique

Vincent RIALLE. Maître de conférences-praticien hospitalier, Dr GBM, Dr éthique médicale et biologique Vincent RIALLE Maître de conférences-praticien hospitalier, Dr GBM, Dr éthique médicale et biologique Responsable de l Unité Fonctionnelle ATMISS «Alzheimer, Technologie et Méthodes d'intervention Sanitaires

More information

REPORT ON THE RESEARCH UNIT: UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES:

REPORT ON THE RESEARCH UNIT: UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Research evaluation REPORT ON THE RESEARCH UNIT: Institut of Ecology and Environmental Sciences (iees) UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Université Pierre et Marie

More information

Public Policy, Intermediaries and Innovation System Performance:

Public Policy, Intermediaries and Innovation System Performance: Public Policy, Intermediaries and Innovation System Performance: A Comparative Analysis of Quebec and Ontario Angelo Dossou-Yovo & Diane-Gabrielle Tremblay Téluq Université du Québec A Montréal (UQAM)

More information

AGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine

AGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine AGENDA Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine April 25, 2017 AGENDA 8:00 am Registration and Continental Breakfast (Guildhall

More information

Fostering Seed Innovation

Fostering Seed Innovation CSTA ACCS Canadian Seed Trade Association L Association canadienne du commerce des semences Fostering Seed Innovation Canadian Seed Trade Association L Association canadienne du commerce des semences About

More information

Supporting the Use of Health Technology Assessments by Decision-Makers

Supporting the Use of Health Technology Assessments by Decision-Makers DISCUSSION AND DEBATE Supporting the Use of Health Technology Assessments by Decision-Makers Appuyer l utilisation des évaluations des technologies de la santé chez les décideurs JULIE POLISENA, MSC Canadian

More information

Centre for the Advancement of Health Innovations (CAHI)

Centre for the Advancement of Health Innovations (CAHI) Centre for the Advancement of Health Innovations (CAHI) Excellence in Clinical Innovation and Technology Evaluation Monday, April 16 th, 2012 The Old Mill Inn and Spa, Toronto ON Leslie Levin MB, MD, FRCP

More information

Wireless Communications for the Pacific Islands Prof. François Gagnon, PhD, Eng. École de technologie supérieure, Université du Québec

Wireless Communications for the Pacific Islands Prof. François Gagnon, PhD, Eng. École de technologie supérieure, Université du Québec Wireless Communications for the Pacific Islands Prof. François Gagnon, PhD, Eng. École de technologie supérieure, Université du Québec Outline Communication in difficult situations Communication in difficult

More information

Psychotherapist Discovers Service Excellence with RingRx HIPAA Compliant Phone System

Psychotherapist Discovers Service Excellence with RingRx HIPAA Compliant Phone System Psychotherapist Discovers Service Excellence with RingRx HIPAA Compliant Phone System Says, RingRx Checks All the Right Boxes for Quality, Good Value and Simplicity. RingRx Customer Success Story Dr. Mark

More information

Harnessing Evaluation to Drive Innovation in the Health System. Insights from Canada and Australia. Australasian Evaluation Society Conference 2016

Harnessing Evaluation to Drive Innovation in the Health System. Insights from Canada and Australia. Australasian Evaluation Society Conference 2016 Harnessing Evaluation to Drive Innovation in the Health System Insights from Canada and Australia Australasian Evaluation Society Conference 2016 Acknowledgement of Country WestWood Spice acknowledges

More information

Government, an Actor in Innovation

Government, an Actor in Innovation Towards a Québec Innovation Policy Government, an Actor in Innovation Science and Technology in Public Administration Advisory report of the Conseil de la science et de la technologie Summary Governments

More information

Agenda. Genesys Capital Partners. The Opportunity. Our Approach

Agenda. Genesys Capital Partners. The Opportunity. Our Approach MEDT Dinner Presentation September 28, 2005 Agenda Genesys Capital Partners The Opportunity Our Approach Genesys Capital Partners Genesys Capital Partners Successful Track Record Management experience

More information

Design for value DfV

Design for value DfV Design for value DfV Dan A. Seni, P. Eng., Ph.D. School of Management Université du Québec à Montréal Canada seni.dan@uqam.ca Publication: Dan A. Seni, (2005). Function Models : A General Framework for

More information

Public Release Date: Tuesday July 26, 2016, 6:30 am EDT

Public Release Date: Tuesday July 26, 2016, 6:30 am EDT Three in Ten (29%) Pokémon GO Players Agree It s Taking Over Their Life, They ve Skipped Day-to-Day Activities (29%) or Missed School or Work to Play (16%) Two in Ten (19%) Canadians Aged 13+ Have Downloaded

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value CADTH 2018 2021 STRATEGIC PLAN Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value Health care costs an estimated $242 billion annually

More information

SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE

SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE OLDER AUSTRALIANS ARE AFFLUENT, HEALTH LITERATE AND SURPRISINGLY PROACTIVE IN MANAGING THEIR OWN HEALTH AND THEY ARE USING DIGITAL HEALTH TOOLS TO DO

More information

WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010

WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 Prepared & Presented by: Gwen Connon, Contract Specialist, WRHA Contracting Services Sarah Kelso, Manager, Clinical Engineering,

More information

Translational scientist competency profile

Translational scientist competency profile C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective

More information

A novel didactic method for specialist presentations to emergency medicine residents Consultant Chat

A novel didactic method for specialist presentations to emergency medicine residents Consultant Chat A novel didactic method for specialist presentations to emergency medicine residents Consultant Chat Richard Bounds, MD and Jenna Fredette, MD Christiana Care Health System Newark, Delaware, USA I do not

More information

Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI

Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI SAMED, Annual Conference, May 29 th 2014 From «Does

More information

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered? 3.3 Assessment: National health technology assessment unit 3.3.1 Introduction Health systems throughout the world are struggling with the challenge of how to manage health care delivery in resource-constrained

More information

Open surgery SIMULATION

Open surgery SIMULATION Open surgery SIMULATION ossimtech.com A note from the President and Co-Founder, Mr. André Blain Medical education and surgical training are going through exciting changes these days. Fast-paced innovation

More information

François Grémy, a humanist and information sciences pioneer

François Grémy, a humanist and information sciences pioneer François Grémy, a humanist and information sciences pioneer Patrice Degoulet 1, Marius Fieschi 2, Marcel Goldberg 3, Roger Salamon 4 1 René Descartes University, Paris, France, 2 Aix Marseille University,

More information

Ivanhoé Cambridge appoints Claude Sirois President, Ivanhoé Cambridge Retail

Ivanhoé Cambridge appoints Claude Sirois President, Ivanhoé Cambridge Retail NEWS RELEASE FOR IMMEDIATE RELEASE Ivanhoé Cambridge appoints Claude Sirois President, Ivanhoé Cambridge Retail An Executive Committee made up of seasoned professionals Montreal, Quebec, May 20, 2016 Ivanhoé

More information

Mapping of HTA in Europe " Regulatory and Reimbursement Atlas"

Mapping of HTA in Europe  Regulatory and Reimbursement Atlas CIRS- Centre for Innovation in Regulatory Science 1 CONSENSUS TRUST ACCESS Mapping of HTA in Europe " Regulatory and Reimbursement Atlas" Tina Wang Manager, HTA Programme twang@cirsci.org 20 May 2016 Brussels,

More information

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer 13 December 2007 A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer Project Team Leela Barham Michelle Ng NERA Economic Consulting 15 Stratford Place London W1C 1BE United Kingdom Tel:

More information

Taylor & Francis journals Canadian researcher survey 2010

Taylor & Francis journals Canadian researcher survey 2010 Taylor & Francis journals Canadian researcher survey 2010 Executive summary Canadian research is at a time of flux. There are pressures on funding and researchers time, increasing emphasis on metrics such

More information

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes Service Line: Health Technology Management Program Version: 1.0 Publication Date: September 2017 Report Length:

More information

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on

More information

HISA UX CoP Workshop: Usability and User Experience Stories from the front lines

HISA UX CoP Workshop: Usability and User Experience Stories from the front lines HISA UX CoP Workshop: Usability and User Experience Stories from the front lines Associate Professor Chris Bain MBBS, M. Info. Tech., PhD (Info. Sys.), MACS, AFCHSM, FACHI Founder HealthTech-UX (HTUX)

More information

Use of the Graded Approach in Regulation

Use of the Graded Approach in Regulation Use of the Graded Approach in Regulation New Major Facilities Licensing Division Directorate of Regulatory Improvement and Major Projects Management Background Information for Meeting of the Office for

More information

Aging & Arts (AaA) HOW DOES AGE AFFECT THE CREATIVE PROCESS?

Aging & Arts (AaA) HOW DOES AGE AFFECT THE CREATIVE PROCESS? Aging & Arts (AaA) 2017-2018 HOW DOES AGE AFFECT THE CREATIVE PROCESS? The methodology adopted by Age (or Aging) Studies is currently nourishing a dynamic wave of interdisciplinary research in both the

More information

Before I talk through the strategy itself, I want to tell you more about why

Before I talk through the strategy itself, I want to tell you more about why This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting

More information

Section 3 The Desired Human Resource System

Section 3 The Desired Human Resource System Section 3 The Desired Human Resource System 1 Reform of the Human Resource System People are the main actors in promoting science, technology and innovation. One of the most important pillars To strongly

More information

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only CCG 360 o stakeholder survey 2014 Main report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of health and care

More information

How AI and wearables will take health to the next level - AI Med

How AI and wearables will take health to the next level - AI Med How AI and wearables will take health to the next level By AIMed 22 By Nick Van Terheyden, MD Wearables are everywhere and like many technology terms the early entrants have become synonymous and part

More information

FSAA Strategic Research Plan

FSAA Strategic Research Plan Adopted by le Conseil de la FSAA du 13.01.2015 FSAA Strategic Research Plan 2015 2020 Preamble The Strategic Research Plan of the Faculty of Agriculture and Food Sciences (FSAA) fits within the framework

More information

Innovation in HTA: What is the additional value?

Innovation in HTA: What is the additional value? Innovation in HTA: What is the additional value? Stirling Bryan Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute School of Population & Public Health, UBC My co-authors

More information

Rational Use of New Medicines

Rational Use of New Medicines Rational Use of New Medicines A Challenge for Health Policy Prof Ken Paterson EuroDURG/ISPE - Antwerp 2 December 2011 Increasing Pressures in all Health-Care Systems Population demography Aging population

More information

Public Information and Disclosure RD/GD-99.3

Public Information and Disclosure RD/GD-99.3 Public Information and Disclosure RD/GD-99.3 March, 2012 Public Information and Disclosure Regulatory Document RD/GD-99.3 Minister of Public Works and Government Services Canada 2012 Catalogue number CC172-82/2012E-PDF

More information

Building a Smart Specialization in Regions based on Social Network Analysis Tools. The Case of Franche-Comté Region Sana MRIZAK et Fabienne PICARD

Building a Smart Specialization in Regions based on Social Network Analysis Tools. The Case of Franche-Comté Region Sana MRIZAK et Fabienne PICARD Building a Smart Specialization in Regions based on Social Network Analysis Tools. The Case of Franche-Comté Region Sana MRIZAK et Fabienne PICARD Ecole d Eté du Réseau de Recherche sur l Innovation 2013,

More information

INDUSTRIAL KNOW-HOW & ORTHOPAEDIC SURGERY.

INDUSTRIAL KNOW-HOW & ORTHOPAEDIC SURGERY. INDUSTRIAL KNOW-HOW & ORTHOPAEDIC SURGERY www.groupe-lepine.com A new century for groupe lépine : As a French company steeped in the business of orthopaedics, we are ready to take on new challenges in

More information

The research and creation approach in digital literature

The research and creation approach in digital literature The research and creation approach in digital literature Serge Bouchardon University of Technology of Compiegne (France), COSTECH Laboratory Introduction I would like to share some thoughts and questions

More information

THE FONDS DE RECHERCHE DU QUÉBEC AN OVERVIEW

THE FONDS DE RECHERCHE DU QUÉBEC AN OVERVIEW THE FONDS DE RECHERCHE DU QUÉBEC AN OVERVIEW THE CHIEF SCIENTIST OF QUÉBEC Rémi Quirion is the chief scientist of Québec. His position at the interface of the three research Funds enables him to build

More information

The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured?

The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured? The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured? 2-3 April 2014 PROGRAMME Woodlands Park Hotel, Cobham, Surrey, UK CENTRE

More information

STRATEGIC FRAMEWORK Updated August 2017

STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK Updated August 2017 STRATEGIC FRAMEWORK The UC Davis Library is the academic hub of the University of California, Davis, and is ranked among the top academic research libraries in North

More information

MEDTEQ FORUM PROGRAM 2018 Innovating Beyond Borders

MEDTEQ FORUM PROGRAM 2018 Innovating Beyond Borders MEDTEQ FORUM PROGRAM 2018 Innovating Beyond Borders Diane Côté CEO MEDTEQ "Innovation: over the past 5 years, members of MEDTEQ have declined this word every day, each to the flavor of its area of expertise.

More information

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current: Curriculum Vita Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation Career History: Current: Managing Editor, The Keckley Report (2006-present) The Keckley Report is a weekly blog

More information

REPORT ON THE RESEARCH UNIT: Langues et Civilisations à Tradition Orale LaCiTO

REPORT ON THE RESEARCH UNIT: Langues et Civilisations à Tradition Orale LaCiTO Research evaluation REPORT ON THE RESEARCH UNIT: Langues et Civilisations à Tradition Orale LaCiTO UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Université Sorbonne Nouvelle

More information

What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012

What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report: The Case for Change 1 Report of What We Heard: The Case for Change Consultation

More information

PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS

PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS PRB 99-46E PATENT PROTECTION FOR PHARMACEUTICAL PRODUCTS IN CANADA CHRONOLOGY OF SIGNIFICANT EVENTS Margaret Smith Law and Government Division 30 March 2000 Revised 31 May 2000 PARLIAMENTARY RESEARCH BRANCH

More information

Mining and Metal Extraction in Canada

Mining and Metal Extraction in Canada Mining and Metal Extraction in Canada I am Ahmet Deniz Bas, a PhD student in the field of metallurgical engineering at Laval University, Quebec, Canada. I plan to make interviews on mining and metal extraction

More information

PROJECT IMPLEMENTATION PROPOSAL INTELLECTUAL PROPERTY (IP) AND INFORMAL ECONOMY (RECOMMENDATION 34)

PROJECT IMPLEMENTATION PROPOSAL INTELLECTUAL PROPERTY (IP) AND INFORMAL ECONOMY (RECOMMENDATION 34) E CDIP/8/3 REV./STUDY/INF/1 ORIGINAL: ENGLISH DATE: JULY 25, 2012 PROJECT IMPLEMENTATION PROPOSAL INTELLECTUAL PROPERTY (IP) AND INFORMAL ECONOMY (RECOMMENDATION 34) WIPO s Economic and Statistics Division

More information

Sustainable information culture: what perception do information professionals have on their practices

Sustainable information culture: what perception do information professionals have on their practices Sustainable information culture: what perception do information professionals have on their practices Dominique Maurel, Associate Professor École de bibliothéconomie et des sciences de l information Université

More information

IMHA Research. In short it is addressing two questions:

IMHA Research. In short it is addressing two questions: IMHA Research Vision IMHA Research will promote and facilitate the conduct of maritime health research and encourage collaboration within and across disciplinary boundaries to establish evidence that will

More information

Strategic Plan UNIGE The University of Geneva in 2025

Strategic Plan UNIGE The University of Geneva in 2025 Strategic Plan 2015 UNIGE 2.025 The University of Geneva in 2025 INTRODUCTION The period we are now entering is both uncertain and fascinating. Many changes will occur over the next decade, and the University

More information

Speaking Notes for. Yves Bastien Commissioner for Aquaculture Development Fisheries and Oceans Canada

Speaking Notes for. Yves Bastien Commissioner for Aquaculture Development Fisheries and Oceans Canada Speaking Notes for Yves Bastien Commissioner for Aquaculture Development Fisheries and Oceans Canada at How To Farm The Seas: The Science, Economics, & Politics of Aquaculture Rodd Brudenell River Resort

More information

Counterfeit, Falsified and Substandard Medicines

Counterfeit, Falsified and Substandard Medicines Meeting Summary Counterfeit, Falsified and Substandard Medicines Charles Clift Senior Research Consultant, Centre on Global Health Security December 2010 The views expressed in this document are the sole

More information

Intellectual Property Policy. DNDi POLICIES

Intellectual Property Policy. DNDi POLICIES Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments

More information

W5 Application of Gamification in Healthcare and Outcomes measurement : Improving treatment compliance and research engagement

W5 Application of Gamification in Healthcare and Outcomes measurement : Improving treatment compliance and research engagement W5 Application of Gamification in Healthcare and Outcomes measurement : Improving treatment compliance and research engagement MICHAEL ACQUADRO, JOHN HARRISON, JURRIAAN VAN RIJSWIJK Discussion leaders

More information

Chapter 1 Introduction

Chapter 1 Introduction Chapter 1 Introduction Statistics is the science of data. Data are the numerical values containing some information. Statistical tools can be used on a data set to draw statistical inferences. These statistical

More information

ABORIGINAL CANADIANS AND THEIR SUPPORT FOR THE MINING INDUSTRY: THE REALITY, CHALLENGES AND SOLUTIONS

ABORIGINAL CANADIANS AND THEIR SUPPORT FOR THE MINING INDUSTRY: THE REALITY, CHALLENGES AND SOLUTIONS November 17, 2014 ABORIGINAL CANADIANS AND THEIR SUPPORT FOR THE MINING INDUSTRY: THE REALITY, CHALLENGES AND SOLUTIONS 1 PREPARE TO BE NOTICED ABORIGINAL CANADIANS AND THEIR SUPPORT FOR THE MINING INDUSTRY:

More information

Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada

Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada Canada s Intellectual Property (IP) Strategy submission from Polytechnics Canada 170715 Polytechnics Canada is a national association of Canada s leading polytechnics, colleges and institutes of technology,

More information

EXECUTIVE SUMMARY. St. Louis Region Emerging Transportation Technology Strategic Plan. June East-West Gateway Council of Governments ICF

EXECUTIVE SUMMARY. St. Louis Region Emerging Transportation Technology Strategic Plan. June East-West Gateway Council of Governments ICF EXECUTIVE SUMMARY St. Louis Region Emerging Transportation Technology Strategic Plan June 2017 Prepared for East-West Gateway Council of Governments by ICF Introduction 1 ACKNOWLEDGEMENTS This document

More information

Knitting the Digital Library Together. Canadian National Heritage Digitization Strategy Foundational Assembly Report

Knitting the Digital Library Together. Canadian National Heritage Digitization Strategy Foundational Assembly Report Knitting the Digital Library Together Canadian National Heritage Digitization Strategy Foundational Assembly Report Canadian National Heritage Digitization Strategy November 2016 Introduction Over 130

More information

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development Unclassified DAF/COMP/M(2014)2/ANN6/FINAL DAF/COMP/M(2014)2/ANN6/FINAL Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 10-Feb-2015

More information

Adopting Standards For a Changing Health Environment

Adopting Standards For a Changing Health Environment Adopting Standards For a Changing Health Environment November 16, 2018 W. Ed Hammond. Ph.D., FACMI, FAIMBE, FIMIA, FHL7, FIAHSI Director, Duke Center for Health Informatics Director, Applied Informatics

More information

PRIVACY ANALYTICS WHITE PAPER

PRIVACY ANALYTICS WHITE PAPER PRIVACY ANALYTICS WHITE PAPER European Legal Requirements for Use of Anonymized Health Data for Research Purposes by a Data Controller with Access to the Original (Identified) Data Sets Mike Hintze Khaled

More information

2018 Guide to Engineering Compensation

2018 Guide to Engineering Compensation 218 Guide to Engineering Compensation An Exploration of 12 Key Engineering Disciplines Across the Product Development & Manufacturing Lifecycle 18 talent solutions 218 Guide to Engineering Compensation

More information

REPORT ON THE RESEARCH UNIT: UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES:

REPORT ON THE RESEARCH UNIT: UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Research evaluation REPORT ON THE RESEARCH UNIT: Laboratoire Physico-Chimie Curie PCC UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Université Pierre et Marie Curie Institut

More information

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta

More information

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information